维普期刊资源整合服务平台（V6.5）

92篇 您的检索式：作者名="MONTEMURRO F"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast patients:anti-tumor activity and peripheral blood progenitor cell mobilization capability显示文摘	Ballestrero A Montemurro F Gonella R	2003	Breast Cancer Res Treat2003，82，3：	1
2	Trastuzum ab:mechanism of action, resistance and Future perspectives in Her-2 overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
3	Prevention and treatment of febrile neutropenia 显示文摘	MONTEMURRO F GALLICCHID M AGLIETTA M	1997	Tumori1997，83，2：	1
4	Immunophenotypic heterogeneity of hyalinzing trabecular tumors of the thyroid显示文摘	Papotti M Riella P Montemurro F	1997	Histopathology1997，31，6：	1
5	Lapatinib: a dual inhibitor of EGFR and HER-2 tyrosine kinase activ- ity 显示文摘	Montemurro F Valabrega G Aglietta M	2007	Expert Opin Biol Ther2007，7，2：	1
6	Our experience of nipple reconstruction using the C-V flap technique: 1 year evaluati- on显示文摘	Valdatta L Montemurro P Tamborini F	2009	J Plast Reconstr Aesthet Surg2009，62，10：	1
7	Selectively enhanced cellular signaling by Gi proteins in essential hypertension: Gi2, Gi3,Gβ1, and Gβ2 are not mutated显示文摘	Pietruck F Moritz A Montemurro M	1996	Circ Res1996，79，：	1
8	Clinical outcome of adjuvant endocrine treatment according to PR and HER2 status in early breast cancer显示文摘	Ponzone R Montemurro F Maggiorotto F	2006	Ann Oncol2006，17，16：	1
9	Outcome of pa- tients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy显示文摘	Montemurro F Donadio M Clavarezza M	2006	Oncologist2006，11，4：	1
10	Trastuzumab:mechanism of action,resistance and future perspectives in HER-2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
11	Trastuzumab:mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，：	1
12	Trastuzum-ab: mechanism of action, resistance and future perspectives inHER2-overexpressing breast cancer 显示文摘	VALABREGA G MONTEMURRO F AGUETTA M	2007	Ann Oncol2007，18，6：	1
13	Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1
14	Selected highlights from the 26th San Antonio Breast Cancer Symposium显示文摘	Montemurro F Aglietta M	2004	Expert Opinion on Pharmacothery2004，5，4：	1
15	Long term effects of or- ganic amend ments on soil fertility:A review 显示文摘	DIACONO M MONTEMURRO F	2010	Agronomy for Sustainable Development2010，30，2：	1
16	Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era显示文摘	Montemurro F Redana S Viale G	2008	Clin Breast Cancer2008，8，5：	1
17	Retrospective evaluation of clinical outcomes in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy in the pre-lapatinib era显示文摘	Montemurro F Redana S Viale G	2008	Clin Breast Cancer2008，8，5：	1
18	Effects of urease and nitrification inhibitors application on urea fate in soil and nitrate accumulation in lettuce显示文摘	Montemurro F Capotorti G Lacertosa G	1998	Journal of Plant Nutrition1998，21，：	1
19	Trastuzumab-based combination therapy for breast-cancer显示文摘	Montemurro F Valabrega G Aglietta M	2004	Expert Opin Pharmatother2004，5，：	1
20	Trastuzumab:mechanism of action,resistance and future perspectives in HER2-overexpressing breast cancer显示文摘	Valabrega G Montemurro F Aglietta M	2007	Ann Oncol2007，18，6：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示